So-Young International Inc
Q2 2026 Earnings
Market Reaction
Did SY Beat Earnings? Q2 2026 Results
So-Young International delivered a sharply mixed second quarter, beating Wall Street's loss expectations by a wide margin while falling well short on revenue. The company posted a GAAP loss of $0.03 per share, beating the consensus estimate of $0.60 per share by 94.98%, extending its streak of beating consensus EPS estimates to four consecutive quarters. Revenue, however, came in at $74.46 million, missing the $478.35 million consensus by 84.43% and declining 80.3% year over year, as the legacy platform business continued to erode. The primary driver of the narrower-than-expected loss was rapid expansion within the aesthetic treatment services segment, which now operates 65 branded centers across 18 major Chinese cities, with same-store sales growth accelerating to 52%. GAAP net loss narrowed 37.0% year over year to $3.34 million, reflecting improving cost discipline even as total cost of revenues rose. Looking ahead, So-Young guided Q3 2026 aesthetic treatment services revenue to between $51.90 million and $53.40 million, representing 91.7% to 97.2% year-over-year growth, as CFO Shannon Shen cited a clear path toward profitability.
- Rapid expansion of branded aesthetic centers driving 129.5% growth in aesthetic treatment services
- Same-store sales growth of 52% vs 14% in Q2 2025
- Active users surged 154% YoY to over 255,300
- Core members grew 24% sequentially, contributing over 80% of aesthetic treatment services revenues
- Quarterly repurchase rate of nearly 70% among core members
- 3.8 percentage-point expansion in aesthetic treatment segment gross margin
- Verified treatment visits increased 145% YoY to approximately 165,200
“Our sustained focus on scale and efficiency yielded another strong quarter for our core aesthetic treatment business. Supported by enhanced medical capabilities, a robust standardized delivery system, and deeper AI integration, we scaled our business more efficiently. This solid execution is validated by a 129.5% year-over-year increase in second-quarter aesthetic treatment services revenues with a 3.8 percentage-point expansion in segment gross margin. Going forward, we will further strengthen our supply chain and accelerate AI-powered transformation to deliver more competitive products and services across our expanding network, laying a solid foundation for sustainable, high-quality growth.”
So-Young International CEO, on the earnings call
Forward Guidance & Outlook
For Q3 2026, So-Young expects aesthetic treatment services revenues to be between RMB352.0 million (US$51.9 million) and RMB362.0 million (US$53.4 million), representing a 91.7% to 97.2% increase from the same period in 2025. CFO Shannon Shen stated the company sees a clear path toward profitability as industry leadership solidifies and economies of scale continue to unfold.
SY YoY Financials
SY Revenue by Segment
Figures from SEC filings and company reports. Not investment advice.